Literature DB >> 2352330

Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production.

S L Kozak1, D Kabat.   

Abstract

Retroviral vectors offer major advantages for gene transfer studies but have not been useful for producing proteins in large quantities. This deficiency has resulted in part from interference to superinfection, which limits the numbers of active proviruses in cells. Recently, we found that these vectors amplify when they are added as calcium phosphate precipitates to cocultures of cells that package retroviruses into ecotropic and amphotropic host range envelopes. Helper-free virions from either cell type can infect the other without interference, resulting in theoretically limitless back-and-forth (ping-pong) vector replication. In initial studies, however, amplifications of a vector that contained the human growth hormone gene ceased when the hormone produced was 0.3% or less of cellular protein synthesis. This limit was caused by two factors. First, recombinant shutoff viruses that are replication defective and encode envelope glycoproteins form at a low probability during any round of the vector replication cycle and these spread in cocultures, thereby establishing interference. Single cells in shutoff cocultures therefore synthesize both ecotropic and amphotropic envelope glycoproteins, and they release promiscuous (presumably hybrid) virions. The probability of forming shutoff viruses before the vector had amplified to a high multiplicity was reduced by using small cocultures. Second, cells with large numbers of proviruses are unhealthy and their proviral expression can be unstable. Stable expresser cell clones were obtained by selection. Thereby, cell lines were readily obtained that stably produce human growth hormone as 4 to 6% of the total protein synthesis. A ping-pong retroviral vector can be used for high-level protein production in vertebrate cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2352330      PMCID: PMC249616     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Improved retroviral vectors for gene transfer and expression.

Authors:  A D Miller; G J Rosman
Journal:  Biotechniques       Date:  1989-10       Impact factor: 1.993

2.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

3.  Molecular mechanisms involved in morphological variation of avian sarcoma virus-infected rat cells.

Authors:  D J Chiswell; P J Enrietto; S Evans; K Quade; J A Wyke
Journal:  Virology       Date:  1982-01-30       Impact factor: 3.616

4.  Retrovirus transduction: segregation of the viral transforming function and the herpes simplex virus tk gene in infectious Friend spleen focus-forming virus thymidine kinase vectors.

Authors:  A L Joyner; A Bernstein
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

5.  Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection.

Authors:  R H Bassin; S Ruscetti; I Ali; D K Haapala; A Rein
Journal:  Virology       Date:  1982-11       Impact factor: 3.616

6.  Frequent hereditable shutdown of murine retrovirus gene expression in murine cell lines.

Authors:  R K Bestwick; C A Machida; E Polonoff; D Kabat
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

7.  Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera.

Authors:  P Clapham; K Nagy; R A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

8.  Genomic masking and rescue of dual-tropic murine leukemia viruses: role of pseudotype virions in viral lymphomagenesis.

Authors:  M Haas; V Patch
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

9.  Clonal growth of chinese hamster cell lines in protein-free media.

Authors:  W G Hamilton; R G Ham
Journal:  In Vitro       Date:  1977-09

10.  Human growth hormone DNA sequence and mRNA structure: possible alternative splicing.

Authors:  F M DeNoto; D D Moore; H M Goodman
Journal:  Nucleic Acids Res       Date:  1981-08-11       Impact factor: 16.971

View more
  33 in total

1.  Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration.

Authors:  W P Lynch; A H Sharpe; E Y Snyder
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Efficient retroviral-mediated gene transfer into human B lymphoblastoid cells expressing mouse ecotropic viral receptor.

Authors:  B W Baker; D Boettiger; E Spooncer; J D Norton
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

3.  Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges.

Authors:  C M Lynch; A D Miller
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cells.

Authors:  Theresa J Berndt; Bernhard Bielesz; Theodore A Craig; Peter J Tebben; Desa Bacic; Carsten A Wagner; Stephen O'Brien; Susan Schiavi; Jurg Biber; Heini Murer; Rajiv Kumar
Journal:  Pflugers Arch       Date:  2005-09-09       Impact factor: 3.657

5.  Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process.

Authors:  D C Siess; S L Kozak; D Kabat
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Origin and rapid evolution of a novel murine erythroleukemia virus of the spleen focus-forming virus family.

Authors:  M E Hoatlin; E Gomez-Lucia; F Lilly; J H Beckstead; D Kabat
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  High-titer packaging cells producing recombinant retroviruses resistant to human serum.

Authors:  F L Cosset; Y Takeuchi; J L Battini; R A Weiss; M K Collins
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

Review 8.  Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques.

Authors:  M E Hoatlin; S L Kozak; C Spiro; D Kabat
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

9.  Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction.

Authors:  S D Rettinger; S C Kennedy; X Wu; R L Saylors; D G Hafenrichter; M W Flye; K P Ponder
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

10.  Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells.

Authors:  W Paulus; I Baur; F M Boyce; X O Breakefield; S A Reeves
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.